NABC Report 17: Agricultural Biotechnology: Beyond Food and Energy to Health and the Environment
Browse by
Published 2005 by NABC.
This conference focused on issues such as plants as new sources of medicinals; bioremediation, phytosensing, and ecorestoration; gene-to-product development; and regulation, consumer acceptance, and risk management.
The products and processes addressed here are almost all at the research stage, whereas there is up to 15 years’ experience with commercial products in the enzyme and crop areas. Economic and environmental benefits of the products discussed could be large, e.g. plants engineered to produce low-cost medicinals with ease of scale-up stated as a unique advantage compared to traditional methods of manufacturing pharmaceuticals, plants that remediate soils in situ instead of wholesale excavation and landfill placement, and trees modified for lower lignin content so as to decrease processing costs while increasing pulp yields with less environmental impact. However, all have major not-yet-well-defined regulatory hurdles to navigate. This report provides cutting-edge information on a cross-section of these novel products and processes and includes open dialog on regulatory and related issues. It emerged that some academic scientists believe that biotechnology products are over-regulated, because regulation is based on process not trait.
All, including those from industry and the Biotechnology Industry Organization, support the necessity for regulation. The bottom line is cautious optimism for commercial use of these products; at this time there are few green lights, many yellow and some red.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Recent Submissions
-
The nature of change: Towards sensible regulation of transgenic crops based on lessons from plant breeding, biotechnology and genomics
(NABC, 2005)Literature contains many suggestions that plant genomes are highly variable. One early indication was the discovery that maize inbreds differ in the number of rDNA copies. Until the advent of genetic engineering technology ... -
The importance of stewardship in agricultural biotechnology
(NABC, 2005)The Biotechnology Industry Organization (BIO), has introduced a training program laying out principles for confining plants that make pharmaceuticals and industrial products. Workshops dealing with compliance aspects ... -
Biological confinement of GEOs: Opportunities for reducing environmental risks?
(NABC, 2005)The 2000 federal government interagency review of regulatory oversight of biotechnology products revealed that ensuring confinement could become a regulatory requirement for approval of some transgenic organisms. In 2001, ... -
Panel discussion/ Q&A: Regulation, consumer acceptance, and risk management
(NABC, 2005)Panelists expressed highly critical opinions of industry, government and universities regarding agricultural biotechnology and its products, especially those from cloned animals and PMPs from food crops, identified the ... -
Creating the Proper Environment for Acceptance of Agricultural Biotechnology
(NABC, 2005)The past 10 years have been extremely successful for the biotechnology industry. Products that are herbicide-tolerant or produce their own insecticide to control specific pests. These varieties have been widely adopted by ... -
Liability prevention and biotechnology: A brief history of successful industrial stewardship
(NABC, 2005)There are regulatory and liability hurdles standing in the way of launching a new transgenic product. Despite past successes, and the knowledge gained from failures and near misses, the road to future commercial success ... -
The application of biotechnology to sustainable forestry
(NABC, 2005)Forest genetics is only now reaching the stage at which genetically superior trees are being planted. Biotechnology is being applied to this new germplasm base. ArborGen’s mission is to develop and commercialize technologies, ... -
Commercialization of a protein product from transgenic maize
(NABC, 2005)Bovine trypsin can be synthesized in transgenic maize, nut lack of public acceptance is the major barrier to producing pharmaceutical or industrial products in plants. Response to this public distrust has driven current ... -
Panel discussion/ Q&A: Gene-to-Product Development
(NABC, 2005)There is a new initiative to assist in the navigation of regulatory requirements for specialty or minor crops: the Specialty Crops Regulatory Initiative. It should assist public-sector and small private companies in meeting ... -
Regulating pharmaceutical plants: meeting the challenge
(NABC, 2005)USDA/APHIS has regulated transgenic organisms since 1987, and in 2002 established Biotechnology Regulatory Services (BRS) to place a renewed emphasis and priority on biotechnology. APHIS has authorized more than 10,000 ...
RSS 1.0